Mackie Research Capital Corp. analyst Nikhil Thadani explained how a recent milestone may signify the start of a revenue growth spurt for this supplier of power electronics for energy storage systems.read more >
One analyst believes 2018 could mark a 'dramatic turnaround' for this biotech company, which is at the forefront of using three-dimensional telomere analysis to personalize medical treatment.read more >
As 2018 begins, John McCamant, editor of Medical Technology Stock Letter, reviews several 2017 top performers, discusses the turnaround at the FDA, and profiles one company with an innovative non-statin LDL cholesterol in the pipeline.read more >
Michael King of JMP Securities provides a comprehensive round-up of companies he has selected for the 2018 Biotech Watchlist—companies in immuno-oncology, gene editing, and other indications that he believes offer promising opportunities for patients and investors.
read more >
Ron Struthers of Struthers' Resource Stock Report takes a look back at gold's performance in the last quarter of 2017, and describes a producer he'll be adding to his portfolio in early 2018.
read more >
Michael Sheikh for Streetwise Reports (01/04/2018)
As social media has evolved, it has attracted more and more users. Michael Sheikh of Falcon Strategic Research discusses a company with an app that he believes will break through the constraints of social media.read more >